AbbVie's flagship drug Humira is facing competition from biosimilars, but the company is expected to offset revenue losses in the segment with Skyrizi & Rinvoq. Two real growth drivers for AbbVie are ...
Please provide your email address to receive an email when new articles are posted on . Humira biosimilar Amjevita can cost $1,558 for commercial plans, a discount of 14% compared with Humira’s 2020 ...
As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback